Regeneron (REGN), Sanofi (SNY) Announce Publication of Positive Dupixent Phase 3 Data as AD Treatment

October 3, 2016 6:32 AM

Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) and Sanofi (NYSE: SNY) announce that detailed results from LIBERTY AD SOLO 1 and SOLO ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found